GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (FRA:AS0) » Definitions » Net Interest Income (for Banks)

DMS Imaging (FRA:AS0) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is DMS Imaging Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


DMS Imaging (FRA:AS0) Business Description

Industry
Traded in Other Exchanges
Address
7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.